- Home
- BDSX vs SVII Comparison
BDSX vs SVII Comparison
Compare BDSX & SVII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- SVII
- Stock Information
- Founded
- BDSX 2005
- SVII 2021
- Country
- BDSX United States
- SVII United States
- Employees
- BDSX N/A
- SVII N/A
- Industry
- BDSX Precision Instruments
- SVII Blank Checks
- Sector
- BDSX Health Care
- SVII Finance
- Exchange
- BDSX Nasdaq
- SVII Nasdaq
- Market Cap
- BDSX 245.3M
- SVII 248.9M
- IPO Year
- BDSX 2020
- SVII 2022
- Fundamental
- Price
- BDSX $1.69
- SVII $11.32
- Analyst Decision
- BDSX Strong Buy
- SVII
- Analyst Count
- BDSX 4
- SVII 0
- Target Price
- BDSX $3.08
- SVII N/A
- AVG Volume (30 Days)
- BDSX 239.8K
- SVII 14.2K
- Earning Date
- BDSX 11-05-2024
- SVII 01-01-0001
- Dividend Yield
- BDSX N/A
- SVII N/A
- EPS Growth
- BDSX N/A
- SVII 36.87
- EPS
- BDSX N/A
- SVII 0.37
- Revenue
- BDSX $60,902,000.00
- SVII N/A
- Revenue This Year
- BDSX $48.06
- SVII N/A
- Revenue Next Year
- BDSX $29.97
- SVII N/A
- P/E Ratio
- BDSX N/A
- SVII $30.53
- Revenue Growth
- BDSX 46.25
- SVII N/A
- 52 Week Low
- BDSX $1.15
- SVII $10.72
- 52 Week High
- BDSX $2.21
- SVII $11.30
- Technical
- Relative Strength Index (RSI)
- BDSX 44.41
- SVII 84.27
- Support Level
- BDSX $1.66
- SVII $11.20
- Resistance Level
- BDSX $1.80
- SVII $11.23
- Average True Range (ATR)
- BDSX 0.08
- SVII 0.01
- MACD
- BDSX -0.01
- SVII 0.01
- Stochastic Oscillator
- BDSX 38.46
- SVII 100.00
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.